Cannabinoid Profile: CBD
Cannabidiol, or CBD, is a cannabinoid which has recently emerged from the looming shadow of is more famous cousin, tetrahydrocannabinol, or THC. The recent history of medical cannabis is one that is increasingly focused on CBD, as research is finding that it may have potential therapeutic use for several ailments. In addition, unlike THC, it does not have psychotropic effects, meaning there is no "high" associated with its consumption.
Unfortunately, most cannabis strains in existence today are the results of generations of crossbreeding that has led to much higher potencies of THC while simultaneously leading to a diminished output of CBD. In fact, most modern cannabis strains contain less than 0.1% CBD. Luckily, renewed medical interest has led contemporary breeders to begin developing strains with higher CBD content, and there is an ever-growing number of those strains available today.
Below we present links to original research currently being carried out around the world into CBD's medical potential.
CBD Medical Research
Cancer: Cannabidiol as potential anticancer drug
Cancer: Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
Epilepsy: Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Schizophrenia: Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Stress: The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system